Scintimammography: Better detection of small-sized lesions with tomoscintigraphic than planar images, a phantom study

Nuclear Medicine Communications

Volumn 22, Issue 9, 2001, Pages 1045-1054

  Garin, E ^a   Devillers, A ^a   Girault, S ^a   Laffont, S ^a   Schill, O ^a   Bernard, A M ^a   Moisan, A ^a   Bourguet, P ^a  

^a CENTRE EUGÈNE MARQUIS   (France)

Author keywords

Breast cancer; MIBI; Scintigraphy; Tomoscintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; BREAST CANCER; BREAST TUMOR; DIAGNOSTIC ACCURACY; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; PHANTOM; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; SIGNAL NOISE RATIO; TOMOSCINTIGRAPHY; TUMOR DIAGNOSIS; TUMOR VOLUME;

BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; PHANTOMS, IMAGING; TECHNETIUM TC 99M SESTAMIBI;

EID: 0034858748     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200109000-00015     Document Type: Review

References (25)

1. Chu CK, Smart CR, Tarone RE. Analyses of breast cancer mortality and stage distribution by age for the health insurance plan clinical trial. J Natl Cancer Inst 1988; 80: 1125-1122.
2. Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish two-county trial. Cancer 1995; 75: 2507-2517.
3. Andersson I, Janzon L. Reduced breast cancer mortality in women under 50: updated results from Malmö mammographic screening program. Monogr Natl Cancer Inst 1997; 22: 63-68.
4. Newman J. Recent advances in breast cancer imaging. Radiol Technol 1999; 71: 35-54.
5. Feig SA. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis and staging. Semin Nucl Med 1999; XXIX: 3-15.
6. 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med 1999; XXIX: 16-40.
7. Mann BD, Giuliano AE, Bassett LW, et al. Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg 1983; 118: 23-24.
8. Niloff PH, Sheiner NM. False-negative mammograms in patients with breast cancer. Can J Surg 1981; 24: 50-52.
9. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and non palpable breast lesions. J Nucl Med 1998; 39: 86-91.
10. 99mTc-sestamibi scintimammography in patients with suspicious breast lesions: comparison of SPET and planar images in the detection of primary tumours and axillary lymph node involvement. Nucl Med Commun 1997; 18: 839-845.
11. Palmedo H, Schomburg A, Grünwald F, Mallmann P, Krebs D, Biersack H-J. Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 1996; 37: 626-630.
12. Becherer A, Helbich T, Staudenherz A, et al. The diagnostic value of planar and SPET scintimammography in different age groups. Nucl Med Commun 1997; 18: 710-718.
13. Buscombe JR, Cwikla JB, Thakrar DS, Parbhoo SP, Hilson AJW. Prone SPET scintimammography. Nucl Med Commun 1999; 20: 237-245.
14. Tiling R, Tatsch K, Sommer H, et al. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging. J Nucl Med 1998; 39: 849-856.
15. 99mTc-sestamibi in the diagnosis of breast carcinoma. Acta Radiol 1999; 40: 176-180.
16. Aziz A, Hashmi R, Ogawa Y, Hayashi K. Tc-99m-MIBI scintimammography; SPECT versus planar imaging. Cancer Biother Radiopharm 1999; 6: 495-500.
17. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994; 178: 491-497.
18. Maublant J, de Latour M, Mestas D, et al. Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 1996; 37: 922-925.
19. Scarfone C, Jaszczak RJ, Li J, et al. Breast tumour imaging using incomplete circular orbit pinole SPET: a phantom study. Nucl Med Commun 1997; 18: 1077-1086.
20. Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrière J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvment. J Nucl Med 1995; 36: 1758-1765.
21. Del Vecchio S, Ciarmiello A, Potena MI, et al. in vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med 1997; 24: 150-159.
22. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.
23. 99mTc-MIBI scintimammography using a dedicated nuclear mammograph. J Nucl Med 1999; 40: 46-51.
24. 99mTc-sestamibi scintimammography by SPEM camera in the management of breast cancer in the elderly. Breast Cancer Res Treat 1998; 48: 159-163.
25. Scopinaro F, Pani R, De Vincentis G, Soluri A, Pellegrini R, Porfiri LM. High resolution scintimammography improves the accuracy of technetium-99m methoxyisobutylisonitrile scintimammography: use of a new dedicated gamma camera. J Nucl Med 1999; 26: 1278-1288